Inventor · disambiguated record
Heather Twin
Also filed as: TWIN HEATHER · TWIN HEATHER CLARE
22 granted patents·8 pending applications·260 citations·filing 2007–2024
95Inventor score
Top patents by PatentIndex Score
30 records- 0197US9718827B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2016·Granted Aug 1, 2017·22 cites·6 claims
- 0297US9340546B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted May 17, 2016·57 cites·6 claims
- 0396US8957078B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Feb 17, 2015·19 cites·82 claims
- 0494US9650381B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted May 16, 2017·19 cites·82 claims
- 0594US8969360B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2013·Granted Mar 3, 2015·25 cites·70 claims
- 0693US10787452B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Sep 29, 2020·5 cites·20 claims
- 0793US8367697B2Kinase inhibitorsVERTEX PHARMA·Filed 2011·Granted Feb 5, 2013·28 cites·17 claims
- 0893US8173635B2Kinase inhibitorsJIMENEZ JUAN-MIGUEL·Filed 2008·Granted May 8, 2012·36 cites·29 claims
- 0991US8569337B2Tri-cyclic pyrazolopyridine kinase inhibitorsJIMENEZ JUAN-MIGUEL·Filed 2010·Granted Oct 29, 2013·19 cites·43 claims
- 1090US8877759B2Aminopyrazines as ATR kinase inhibitorsCHARRIER JEAN-DAMIEN·Filed 2012·Granted Nov 4, 2014·16 cites·34 claims
- 1190US2025223292A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1289US11117900B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2019·Granted Sep 14, 2021·2 cites·17 claims
- 1388US10392391B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2017·Granted Aug 27, 2019·4 cites·20 claims
- 1487US11370798B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Jun 28, 2022·1 cites·13 claims
- 1583US10793563B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 6, 2020·3 cites·28 claims
- 1682US12187731B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·19 claims
- 1780US10988477B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Apr 27, 2021·3 cites·20 claims
- 1880US2025059190A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1975US7622463B2Dihydrodiazepines useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2007·Granted Nov 24, 2009·1 cites·42 claims
- 2068US8022202B2Dihydrodiazepines useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2009·Granted Sep 20, 2011·0 cites·25 claims
- 2162US12084438B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 2259US2014038935A1Dihydrodiazepines useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2359US2022340577A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 2458US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2552US9193722B2Tri-cyclic pyrazolopyridine kinase inhibitorsVERTEX PHARMA·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 2651US8394952B2Dihydrodiazepines useful as inhibitors of protein kinasesKAY DAVID·Filed 2011·Granted Mar 12, 2013·0 cites·18 claims
- 2751US2015291601A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 2841US2013053395A1Pyrazolopyridine kinase inhibitorsJIMENEZ JUAN-MIGUEL·Filed 2012·Application pending·0 cites
- 2941US2015299205A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3033US9067932B2Pyrazolopyridine kinase inhibitorsBOYALL DEAN·Filed 2011·Granted Jun 30, 2015·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Heather Twin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →